South and Central America Hypertrophic and Keloid Scar Treatment Market
No. of Pages: 88 | Report Code: TIPRE00025200 | Category: Life Sciences
No. of Pages: 88 | Report Code: TIPRE00025200 | Category: Life Sciences
South and Central America (SCAM) region consists of Brazil and Rest of SCAM. Brazil is expected to have the major market share in this region. Also, it is projected to grow with highest growth rate. The market for the hypertrophic and keloid scar treatment in the region is expected to grow owing to the increasing accidents, chickenpox or other such cases that leads to hypertrophic or keloid scar formation. Keloids and hypertrophic scars (HTS) result from an overgrowth of fibrous tissue following the healing of a cutaneous injury and may cause morbidity. Several treatment modalities are useful for the control of keloids, though no single modality is entirely sufficient. Brazil offers an extensive range of treatment and prevention options. Brazil has a significant number of visitors every year due to tourist attractions. Therefore, it is an ideal location for patients visiting from other countries seeking uncomplicated access to treatment at affordable prices. For instance, Orlando, Florida, supports patients traveling from South America to access the gold standard in keloid treatment and removal. In Brazil, one such center, namely, International Keloid & Scar Treatment Center, advises an extended range of treatments that provide a tailored treatment to suit each patient's individual needs.
South and Central America has witnessed a growing number of cases of COVID-19 since its outbreak. For example, according to the Worldometer, the number of cases reached 13,382,026, with 366,256 recorded deaths in South America as of January 2021. In Brazil, the first case of COVID-19 was confirmed on February 26, 2020, and now, the cases have reached 7,754,560, with 196,591 deaths. Argentina and Colombia reached 1,648,940 and 1,686,131 cases of COVID-19 as of January 2021. COVID-19 is predicted to result in the region's worst recession, causing the region's GDP to contract by 9.1% in 2020. This is projected to increase the number of poor by 45 million and the highly poor by 28 million. The COVID?19 pandemic is a vital test for the still overburdened and underfunded public health systems of South and Central America. Moreover, it will decrease imports due to disruptions in global trade, further increasing the scarcity of medical supplies and other goods, resulting in a significant price increase.
Strategic insights for the South and Central America Hypertrophic and Keloid Scar Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 248.42 Million |
| Market Size by 2027 | US$ 477.69 Million |
| Global CAGR (2020 - 2027) | 9.8% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2027 |
| Segments Covered |
By Scar Type
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
The geographic scope of the South and Central America Hypertrophic and Keloid Scar Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The hypertrophic and keloid scar treatment market in South and Central America is expected to grow from US$ 248.42 million in 2020 to US$ 477.69 million by 2027; it is estimated to grow at a CAGR of 9.8% from 2020 to 2027. Advantages of laser treatment; Technological advancements have led to the successful use of laser—especially 585 nm PDL, Q-switched 532 nm frequency-doubled Nd: YAG, and CO2 lasers, among other types—for treating hypertrophic and keloid scars. The laser treatment helps prevent scar formation after surgery; it reduces pain and itching and allows movement that is otherwise limited by the scar. The treatment is widely employed to treat hypertrophic and keloid scars caused by burns. According to the “Laser Management of Hypertrophic Burn Scars: a Comprehensive Review,” published in January 2020, burn-related injury follows more than 70% of hypertrophic scars. Similarly, according to the World Health Organization (WHO), burn is the major public health problem. Every year, ~265,000 deaths are registered due to scalds, electrical burns, and other burn forms. Moreover, 90% of the burn incidences are reported in low- and middle-income countries. As excessive collagen deposition leads to the generation of hypertrophic scars that lead to raised scars, laser treatment proves to be effective against them. Moreover, due to being a minimally invasive method, it ensures reduced scar thickness, pain, and postoperative recovery period. It also helps prevent the need for surgical excision and improves skin pigmentation, pliability, height, pruritus, texture, and heat sensitivity, among other skin conditions of the affected areas. Moreover, this treatment procedure proves to be cost-effective, especially for those opting for medical tourism. Owing to such advantages, there is high demand for the laser treatment curing hypertrophic and keloid scars. This is bolstering the growth of the hypertrophic and keloid scar treatment market.
Based on scar type, the hypertrophic and keloid scar treatment market is segmented into hypertrophic and keloid. The hypertrophic segment held the largest share of the market in 2019. Based on product type, the hypertrophic and keloid scar treatment market is segmented into laser products, topical products, injectables, and other products. The injectables segment held the largest share of the market in 2019. Based on end user, the hypertrophic and keloid scar treatment market is segmented into hospitals, clinics, and homecare. The hospitals segment held the largest share of the market in 2019.
A few major primary and secondary sources referred to for preparing this report on the hypertrophic and keloid scar treatment market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Alliance Pharma PLC
The South and Central America Hypertrophic and Keloid Scar Treatment Market is valued at US$ 248.42 Million in 2020, it is projected to reach US$ 477.69 Million by 2027.
As per our report South and Central America Hypertrophic and Keloid Scar Treatment Market, the market size is valued at US$ 248.42 Million in 2020, projecting it to reach US$ 477.69 Million by 2027. This translates to a CAGR of approximately 9.8% during the forecast period.
The South and Central America Hypertrophic and Keloid Scar Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Hypertrophic and Keloid Scar Treatment Market report:
The South and Central America Hypertrophic and Keloid Scar Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Hypertrophic and Keloid Scar Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Hypertrophic and Keloid Scar Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Hypertrophic and Keloid Scar Treatment Market
